Related references
Note: Only part of the references are listed.Molecular mechanisms of disorders of lipid metabolism in chronic kidney disease
Hamid Moradi et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2018)
Endothelial factors in the pathogenesis and treatment of chronic kidney disease Part I: General mechanisms: a joint consensus statement from the European Society of Hypertension Working Group on Endothelin and Endothelial Factors and The Japanese Society of Hypertension
Gian Paolo Rossi et al.
JOURNAL OF HYPERTENSION (2018)
Mechanisms and mitigating factors for venous thromboembolism in chronic kidney disease: the REGARDS study
K. L. Cheung et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Combined Inhibition of Soluble Epoxide Hydrolase and Renin-Angiotensin System Exhibits Superior Renoprotection to Renin-Angiotensin System Blockade in 5/6 Nephrectomized Ren-2 Transgenic Hypertensive Rats with Established Chronic Kidney Disease
Vera Certikova Chabova et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2018)
Association of EPHX2 R287Q Polymorphism with Diabetic Nephropathy in Chinese Type 2 Diabetic Patients
Liang Ma et al.
JOURNAL OF DIABETES RESEARCH (2018)
Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016
Yan Xie et al.
KIDNEY INTERNATIONAL (2018)
Oxylipin profiling of human plasma reflects the renal dysfunction in uremic patients
Da-Yong Hu et al.
METABOLOMICS (2018)
Inflammation-Related Mechanisms in Chronic Kidney Disease Prediction, Progression, and Outcome
Simona E. Mihai et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
Expression of soluble epoxide hydrolase in renal tubular epithelial cells regulates macrophage infiltration and polarization in IgA nephropathy
Qian Wang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2018)
Podocyte-specific soluble epoxide hydrolase deficiency in mice attenuates acute kidney injury
Ahmed Bettaieb et al.
FEBS JOURNAL (2017)
Epoxide metabolites of arachidonate and docosahexaenoate function conversely in acute kidney injury involved in GSK3β signaling
Bing-Qing Deng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Meloxicam fails to augment the reno-protective effects of soluble epoxide hydrolase inhibition in streptozotocin-induced diabetic rats via increased 20-HETE levels
Mohamed M. Katary et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2017)
Association of gain-of-function EPHX2 polymorphism Lys55Arg with acute kidney injury following cardiac surgery
Megan M. Shuey et al.
PLOS ONE (2017)
Active maintenance of endothelial cells prevents kidney fibrosis
Seung Hee Yang et al.
KIDNEY RESEARCH AND CLINICAL PRACTICE (2017)
Increased renal resistive index in type 2 diabetes: Clinical relevance, mechanisms and future directions
Baris Afsar et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2017)
Soluble epoxide hydrolase in podocytes is a significant contributor to renal function under hyperglycemia
Ahmed Bettaieb et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2017)
Pharmacokinetics, pharmacodynamics and adverse event profile of GSK2256294, a novel soluble epoxide hydrolase inhibitor
Aili L. Lazaar et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Mechanisms of triple whammy acute kidney injury
Laura Prieto-Garcia et al.
PHARMACOLOGY & THERAPEUTICS (2016)
Renal Ischemia/Reperfusion Injury in Soluble Epoxide Hydrolase-Deficient Mice
Ye Zhu et al.
PLOS ONE (2016)
Soluble epoxide hydrolase: A potential target for metabolic diseases
Jinlong He et al.
JOURNAL OF DIABETES (2016)
Novel Omega-3 Fatty Acid Epoxygenase Metabolite Reduces Kidney Fibrosis
Amit Sharma et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Insights into the Mechanisms of the Acute Kidney Injury-to-Chronic Kidney Disease Continuum
Koji Takaori et al.
NEPHRON (2016)
Soluble epoxide hydrolase inhibition ameliorates proteinuria-induced epithelial-mesenchymal transition by regulating the PI3K-Akt-GSK-3β signaling pathway
Yaoxian Liang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Inhibition of soluble epoxide hydrolase counteracts the development of renal dysfunction and progression of congestive heart failure in Ren-2 transgenic hypertensive rats with aorto-caval fistula
Ludek Cervenka et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2015)
Cytochrome P450 eicosanoids in hypertension and renal disease
Fan Fan et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2015)
Epoxyeicosatrienoic Acids, Hypertension, and Kidney Injury
John D. Imig
HYPERTENSION (2015)
Transcriptome Analysis in Rat Kidneys: Importance of Genes Involved in Programmed Hypertension
You-Lin Tain et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
New insights into the mechanisms of acute kidney injury in the intensive care unit
Seth D. Glodowski et al.
JOURNAL OF CLINICAL ANESTHESIA (2015)
Change in soluble epoxide hydrolase (sEH) during cisplatin-induced acute renal failure in mice
Terumasa Hashimoto et al.
JOURNAL OF TOXICOLOGICAL SCIENCES (2015)
Genetic Deletion of Soluble Epoxide Hydrolase Attenuates Inflammation and Fibrosis in Experimental Obstructive Nephropathy
Chin-Wei Chiang et al.
MEDIATORS OF INFLAMMATION (2015)
A 3′-UTR Polymorphism in Soluble Epoxide Hydrolase Gene Is Associated with Acute Rejection in Renal Transplant Recipients
Guillermo Gervasini et al.
PLOS ONE (2015)
Impact of soluble epoxide hydrolase inhibition on early kidney damage in hyperglycemic overweight mice
Clothilde Roche et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2015)
Pharmacological inhibition of soluble epoxide hydrolase prevents renal interstitial fibrogenesis in obstructive nephropathy
Jinu Kim et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2015)
Discovery of 1-oxa-4,9-diazaspiro[5.5]undecane-based trisubstituted urea derivatives as highly potent soluble epoxide hydrolase inhibitors and orally active drug candidates for treating of chronic kidney diseases
Yuko Kato et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Inhibition of soluble epoxide hydrolase is renoprotective in 5/6 nephrectomized Ren-2 transgenic hypertensive rats
Petr Kujal et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2014)
Hypertension and kidneys: unraveling complex molecular mechanisms underlying hypertensive renal damage
S. Mennuni et al.
JOURNAL OF HUMAN HYPERTENSION (2014)
Opposite Effects of Gene Deficiency and Pharmacological Inhibition of Soluble Epoxide Hydrolase on Cardiac Fibrosis
Lijuan Li et al.
PLOS ONE (2014)
From sugar to kidney: A never-ending battle
Yu-Feng Lin et al.
JOURNAL OF DIABETES INVESTIGATION (2014)
Inhibition of soluble epoxide hydrolase prevents renal interstitial fibrosis and inflammation
Jinu Kim et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2014)
Determination of the Dominant Arachidonic Acid Cytochrome P450 Monooxygenases in Rat Heart, Lung, Kidney, and Liver: Protein Expression and Metabolite Kinetics
Ahmed A. El-Sherbeni et al.
AAPS JOURNAL (2013)
Mechanisms of acute kidney injury
Pontus B. Persson
ACTA PHYSIOLOGICA (2013)
Novel signalling mechanisms and targets in renal ischaemia and reperfusion injury
A. Kusch et al.
ACTA PHYSIOLOGICA (2013)
Impact of Soluble Epoxide Hydrolase and Epoxyeicosanoids on Human Health
Christophe Morisseau et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 53, 2013 (2013)
Pharmaceuticals and personal care products in the aquatic environment in China: A review
Qingwei Bu et al.
JOURNAL OF HAZARDOUS MATERIALS (2013)
Elevated expression of the Ephx2 mRNA in the kidney of hypertensive ISIAH rats
T. O. Abramova et al.
MOLECULAR BIOLOGY (2013)
Unique mechanistic insights into the beneficial effects of soluble epoxide hydrolase inhibitors in the prevention of cardiac fibrosis
Padmini Sirish et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Upregulation of soluble epoxide hydrolase in proximal tubular cells mediated proteinuria-induced renal damage
Qian Wang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2013)
Epoxyeicosatrienoic Acids Prevent Cisplatin-Induced Renal Apoptosis through a p38 Mitogen-Activated Protein Kinase-Regulated Mitochondrial Pathway
Yingmei Liu et al.
MOLECULAR PHARMACOLOGY (2013)
Genetic disruption of soluble epoxide hydrolase is protective against streptozotocin-induced diabetic nephropathy
Guangzhi Chen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2012)
Soluble epoxide hydrolase inhibition and peroxisome proliferator activated receptor γ agonist improve vascular function and decrease renal injury in hypertensive obese rats
John D. Imig et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2012)
Signaling Mechanisms in the Regulation of Renal Matrix Metabolism in Diabetes
Meenalakshmi M. Mariappan
EXPERIMENTAL DIABETES RESEARCH (2012)
Delivery of AAV2-CYP2J2 Protects Remnant Kidney in the 5/6-Nephrectomized Rat via Inhibition of Apoptosis and Fibrosis
Gang Zhao et al.
HUMAN GENE THERAPY (2012)
Epoxyeicosatrienoic acids: a double-edged sword in cardiovascular diseases and cancer
Dingzhi Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Pharmacokinetics and Pharmacodynamics of AR9281, an Inhibitor of Soluble Epoxide Hydrolase, in Single- and Multiple-Dose Studies in Healthy Human Subjects
Dawn Chen et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Soluble Epoxide Hydrolase Inhibition Exhibits Antihypertensive Actions Independently of Nitric Oxide in Mice with Renovascular Hypertension
Libor Kopkan et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2012)
Investigating mechanisms of chronic kidney disease in mouse models
Allison A. Eddy et al.
PEDIATRIC NEPHROLOGY (2012)
Attenuation of Cisplatin-Induced Renal Injury by Inhibition of Soluble Epoxide Hydrolase Involves Nuclear Factor κB Signaling
Yingmei Liu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Soluble epoxide hydrolase in the generation and maintenance of high blood pressure in spontaneously hypertensive rats
Maarten P. Koeners et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2011)
Role of cytochrome P-450 metabolites in the regulation of renal function and blood pressure in 2-kidney 1-clip hypertensive rats
Alexandra Sporkova et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2011)
A review of personal care products in the aquatic environment: Environmental concentrations and toxicity
John M. Brausch et al.
CHEMOSPHERE (2011)
AMPK Mediates the Initiation of Kidney Disease Induced by a High-Fat Diet
Anne-Emilie Decleves et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Inhibition of soluble epoxide hydrolase contributes to the anti-inflammatory effect of antimicrobial triclocarban in a murine model
Jun-Yan Liu et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2011)
In vivo activity of epoxide hydrolase according to sequence variation affects the progression of human IgA nephropathy
Jung Pyo Lee et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2011)
Mechanism of endothelial dysfunction in chronic kidney disease
Jolanta Malyszko
CLINICA CHIMICA ACTA (2010)
Sorafenib: a clinical and pharmacologic review
Renuka Iyer et al.
EXPERT OPINION ON PHARMACOTHERAPY (2010)
Intrarenal cytochrome P-450 metabolites of arachidonic acid in the regulation of the nonclipped kidney function in two-kidney, one-clip Goldblatt hypertensive rats
Agnieszka Walkowska et al.
JOURNAL OF HYPERTENSION (2010)
Inhibition of the Soluble Epoxide Hydrolase Promotes Albuminuria in Mice with Progressive Renal Disease
Oliver Jung et al.
PLOS ONE (2010)
Attenuation of cisplatin nephrotoxicity by inhibition of soluble epoxide hydrolase
Alan R. Parrish et al.
CELL BIOLOGY AND TOXICOLOGY (2009)
Administration of a substituted adamantyl urea inhibitor of soluble epoxide hydrolase protects the kidney from damage in hypertensive Goto-Kakizaki rats
Jeffrey J. Olearczyk et al.
CLINICAL SCIENCE (2009)
Regulation of Soluble Epoxide Hydrolase (sEH) in Mice with Diabetes: High Glucose Suppresses sEH Expression
Ami Oguro et al.
DRUG METABOLISM AND PHARMACOKINETICS (2009)
Differential Subcellular Distribution and Colocalization of the Microsomal and Soluble Epoxide Hydrolases in Cultured Neonatal Rat Brain Cortical Astrocytes
Seema Rawal et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2009)
Sorafenib has soluble epoxide hydrolase inhibitory activity, which contributes to its effect profile in vivo
Jun-Yan Liu et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases
John D. Imig et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
CRAF inhibition induces apoptosis in melanoma cells with non-V600E BRAF mutations
K. S. M. Smalley et al.
ONCOGENE (2009)
The Soluble Epoxide Hydrolase Inhibitor AR9281 Decreases Blood Pressure, Ameliorates Renal Injury and Improves Vascular Function in Hypertension
John D. Imig et al.
PHARMACEUTICALS (2009)
Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
Scott M. Wilhelm et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Soluble epoxide hydrolase and epoxyeicosatrienoic acids modulate two distinct analgesic pathways
Bora Inceoglu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Genetic variations in soluble epoxide hydrolase and graft function in kidney transplantation
S. H. Lee et al.
TRANSPLANTATION PROCEEDINGS (2008)
Mechanisms of progression of chronic kidney disease
Agnes B. Fogo
PEDIATRIC NEPHROLOGY (2007)
Epoxyeicosatrienoic acids induce growth inhibition and calpain/caspase-12 dependent apoptosis in PDGF cultured 3T6 fibroblast
Diana Nieves et al.
APOPTOSIS (2007)
Increasing or stabilizing renal epoxyeicosatrienoic acid production attenuates abnormal renal function and hypertension in obese rats
Hui Huang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2007)
Action of epoxyeicosatrienoic acids on cellular function
Arthur A. Spector et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
Cell-specific subcellular localization of soluble epoxide hydrolase in human tissues
AE Enayetallah et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2006)
Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes
G Remuzzi et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension
JD Imig et al.
HYPERTENSION (2005)
The prevalence of CYP2C8, 2C9, 2J2, and soluble epoxide hydrolase polymorphisms in African Americans with hypertension
AW Dreisbach et al.
AMERICAN JOURNAL OF HYPERTENSION (2005)
Differential renal gene expression in prehypertensive and hypertensive spontaneously hypertensive rats
JM Seubert et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2005)
Structure of human epoxide hydrolase reveals mechanistic inferences on bifunctional catalysis in epoxide and phosphate ester hydrolysis
GA Gomez et al.
BIOCHEMISTRY (2004)
Vascular localization of soluble epoxide hydrolase in the human kidney
ZG Yu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2004)
Distribution of soluble epoxide hydrolase and of cytochrome P4502C8, 2C9, and 2J2 in human tissues
AE Enayetallah et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2004)
Endothelium-derived hyperpolarizing factor in human internal mammary artery is 11,12-epoxyeicosatrienoic acid and causes relaxation by activating smooth muscle BKCa channels
SL Archer et al.
CIRCULATION (2003)
Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension
JD Imig et al.
HYPERTENSION (2002)
Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids
ZG Yu et al.
CIRCULATION RESEARCH (2000)
Binding of alkylurea inhibitors to epoxide hydrolase implicates active site tyrosines in substrate activation
MA Argiriadi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
